Company: PFSA
Filing Date: 2025-05-15
Form Type: 424B3
Source: 0001213900-25-044417
Chunk: 33

Company: Profusa, Inc.
Filing Date: 2025-05-15
Form: 424B3
Chunk 33
---
holders (including the right to receive further liquidation distributions, if any), subject to applicable law; and (iii) as promptly as reasonably possible following such redemption, subject to the approval of NorthView’s remaining stockholders and NorthView’s Board, dissolve and liquidate, subject in each case to NorthView’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. See the section entitled “ Risk Factors — Risks Related to NorthView and the Business Combination.” The NorthView Initial Stockholders have waived any right to any liquidation distribution with respect to their shares of NorthView Common Stock. In the event of liquidation, there will be no distribution with respect to outstanding NorthView Warrants or NorthView Rights. Accordingly, the NorthView Warrants and the NorthView Rights will expire worthless. Q:What equity stake will current NorthView stockholders and current Profusa shareholders hold in the combined company immediately after consummation of the Business Combination? A:As of the date of this proxy statement/prospectus, there are 5,348,311shares of NorthView Common Stock outstanding, which includes an aggregate of 4,743,750shares of NorthView Common Stock held by the Sponsor. In addition, as of the date of this proxy statement/prospectus, there is outstanding an aggregate of 17,404,250 warrants to acquire NorthView Common Stock, comprised of 7,347,500 private placement warrants held by the Sponsor and Representatives, 9,487,500 public warrants, and 569,250 Representative Warrants. Each whole warrant will entitle the holder thereof to purchase one share of NorthView Common Stock at an exercise price of $11.50 per share. Additionally, there are 1,897,500shares issuable pursuant to the 18,975,000 NorthView Rights outstanding. Therefore, as of the date of this proxy statement/prospectus (without giving effect to the Business Combination and assuming that none of NorthView’s outstanding public shares are redeemed in connection with the Business Combination), NorthView’s fully diluted capitalization would be 24,650,061shares of NorthView Common Stock. xiv

Sponsor and Profusa’s Participating Security Holders have agreed to forfeit or contribute an aggregate of up to 1,300,000shares of New Profusa common stock (the “Inducement Shares”), with Sponsor and Profusa contributing up to 1,040,000shares and 260,000shares, respectively,